Tristel Plc · LSE:TSTL

Tristel — Investor Presentation (May 2022)

10 slides from Tristel's investor presentation, May 12, 2022

  1. Slide 1: Investor Presentation

    Investor Presentation Edinburgh 12 May 2022 CEO: Paul Swinney

  2. Slide 2: The World of Infection Prevention

    THE WORLD OF INFECTION PREVENTION MEDICAL DEVICES SURFACES CORE TECHNOLOGY: ClO2 Chlorine dioxide

  3. Slide 3: Medical Device Disinfection

    MEDICAL DEVICE DISINFECTION UNIQUE SELLING POINTS MULTIPLE USE SITES The only manually applied 1. Ophthalmology: Tonometers high level disinfectant (HLD) 2. ENT: Nasendoscopes 3. A&E: Intubation Laryngoscopes for medical devices 4. GI Endoscopy: Manometry Catheters Trio Wipes System 5. Cardiac surge

  4. Slide 4: Surface Disinfection

    SURFACE DISINFECTION Around the patient and in critical areas within the hospital UNIQUE SELLING POINTS MULTIPLE USE METHODOLOGIES • Sporicidal disinfectant Mopping • Effective against all pathogens of concern (including coronaviruses) • Effective in the shortest known contact times Wiping • Excelle

  5. Slide 5: Sales History Since IPO

    SALES HISTORY SINCE IPO £35,000,000 £30,000,000 £25,000,000 £20,000,000 £15,000,000 £10,000,000 £5,000,000 £-

  6. Slide 6: Growth Drivers – Geographical Expansion

    GROWTH DRIVERS – GEOGRAPHICAL EXPANSION

  7. Slide 7: North America: Good Progress

    NORTH AMERICA: GOOD PROGESS • EPA state-by-state registrations: Jet & Duo ➢ Completion target September 2022 ➢ Skin surface ultrasound opportunity • FDA dossier preparation phase: Duo ULT ➢ Submission target June 2022 • Canada distribution plan in preparation: Duo OPH

  8. Slide 8: Financial Targets FY2020 - 2022

    FINANCIAL TARGETS FY2020 - 2022 • Sales growth in the range of 10% to 15% per annum as an annual average over the three years. • EBITDA margin (excluding share-based payment charge) of at least 25%. • To increase profit before tax (excluding share-based payments) year-on-year, independently of the o

  9. Slide 9: Sales Growth Through the Pandemic

    SALES GROWTH THROUGH THE PANDEMIC 8,000,000 7,000,000 6,000,000 5,000,000 4,000,000 3,000,000 2,000,000 1,000,000 - Jul-Sep 19 Oct-Dec 19 Jan-Mar 20 Apr-Jun 20 Jul-Sep 20 Oct-Dec 20 Jan-Mar 21 Apr-Jun 21 Jul-Sep 21 Oct-Dec 21 -1,000,000 Tristel Medical Devices Cache Surfaces Other Brexit

  10. Slide 10: Tristel: We Have Chemistry

    Tristel WE HAVE CHEMISTRY.

Tristel — Investor Presentation (May 2022) on 6ix